Diagnostic performance of clinical properties and conventional magnetic resonance imaging for determining the IDH1 mutation status in glioblastoma: a retrospective study
Background Glioblastoma (GBM), the most malignant form of gliomas, is a relatively common primary brain tumor in adults. Preoperative identification of isocitrate dehydrogenase 1 (IDH1) mutations in GBM is of critical prognostic importance. The aim of the present study was to explore the feasibility...
Main Authors: | Qun Wang, Jiashu Zhang, Fangye Li, Xinghua Xu, Bainan Xu |
---|---|
Format: | Article |
Language: | English |
Published: |
PeerJ Inc.
2019-06-01
|
Series: | PeerJ |
Subjects: | |
Online Access: | https://peerj.com/articles/7154.pdf |
Similar Items
-
<i>IDH</i> Mutations in Glioma: Double-Edged Sword in Clinical Applications?
by: Alisan Kayabolen, et al.
Published: (2021-07-01) -
Features of epileptiform activity in patients with diagnosed glioblastoma: from genetic and biochemical mechanisms to clinical aspects
by: E. E. Tyagunova, et al.
Published: (2022-12-01) -
IDH1 and IDH2 Gene Mutations in Omani Patients with Acute Myeloid Leukemia: Prognostic Significance and Clinic-pathologic Features
by: Yusra Al Abri, et al.
Published: (2024-01-01) -
Efficacy of Personalized Postoperative Epilepsy Management in Patients with Glioblastoma Utilizing IDH1 Gene Assessment
by: Meng GQ, et al.
Published: (2024-04-01) -
IDH Mutations in Glioma: Molecular, Cellular, Diagnostic, and Clinical Implications
by: Kristian A. Choate, et al.
Published: (2024-10-01)